{
    "2019-12-09": [
        [
            {
                "time": "2018-12-09",
                "original_text": "格隆汇港股聚焦(12.9)︱舜宇光学11月手机镜头出货量升42.9%至1.3亿件长城汽车前11月累计销量达95.429万辆",
                "features": {
                    "keywords": [
                        "舜宇光学",
                        "手机镜头",
                        "出货量",
                        "长城汽车",
                        "销量"
                    ],
                    "sentiment_score": 0.75,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "电子制造",
                        "汽车行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "智通港股公告精选︱(12.9)舜宇光学11月手机镜头出货量同比增42.9%至1.3亿件",
                "features": {
                    "keywords": [
                        "舜宇光学",
                        "手机镜头",
                        "出货量"
                    ],
                    "sentiment_score": 0.8,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "电子制造"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "上海医药(02607)获上实国际累计增持3063.34万股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上实国际",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "上海医药(02607.HK)控股股东上实集团已累计增持公司H股3063.34万股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "上实集团",
                        "控股股东",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "上海医药(601607.SH)：控股股东累计增持3063.34万股H股",
                "features": {
                    "keywords": [
                        "上海医药",
                        "控股股东",
                        "增持",
                        "H股"
                    ],
                    "sentiment_score": 0.85,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "恒指收跌0.01% 林业及木材板块领跌",
                "features": {
                    "keywords": [
                        "恒指",
                        "林业",
                        "木材",
                        "板块",
                        "领跌"
                    ],
                    "sentiment_score": -0.2,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "林业",
                        "木材行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "negative",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "negative"
                }
            },
            {
                "time": "2018-12-09",
                "original_text": "麦格理：予上海医药(2607.HK)“跑赢大市”评级 目标价18.57港元",
                "features": {
                    "keywords": [
                        "麦格理",
                        "上海医药",
                        "跑赢大市",
                        "目标价"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "true",
                    "sector_focus": [
                        "医药行业"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "false",
                    "ts_effect_direction": "neutral"
                }
            }
        ]
    ]
}